Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis
Clinical trial NCT05719311 · COMPLETED
Trial details
- NCT number
- NCT05719311
- Sponsor
- Entero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2023-06-20
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.